Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization
Authors:
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 85 (5) , 1541-1543
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal studyFertility and Sterility, 2005
- Anti‐müllerian hormone as a marker of ovarian reserve*Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Urofollitropin and Ovulation InductionTreatments in Endocrinology, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Anti-Müllerian hormone and its role in ovarian functionMolecular and Cellular Endocrinology, 2003
- Serum anti-Mullerian hormone levels: a novel measure of ovarian reserveHuman Reproduction, 2002
- Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cyclesFertility and Sterility, 2002
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal womenFertility and Sterility, 2002